United States Biotechnology & Medical Research

Protalix Biotherapeutics Inc (PLX)

Track

Track

Protalix Biotherapeutics Inc. saw its most recent insider trading activity on December 19, 2025, when President and CEO Dror Bashan purchased 56,000 shares. This follows a minor sale by Amos Bar-Shalev in November 2025. These transactions represent the latest movements within the company's equity ownership structure.
Ticker: PLX Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Protalix Biotherapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Bashan Dror PRESIDENT AND CEO Executive Director
Transaction date
Purchase
Price
119.29
Quantity 56,389 -12.7%
Value US$1,992,998
1.3
Bar-Shalev Amos Non-Executive Director
Transaction date
Sale
Price
185.62
Quantity 64,768 -7.5%
Value US$3,764,391
3.7
Schwartz Aharon Non-Executive Director
Transaction date
Purchase
Price
14.10
Quantity 75,499 +12.4%
Value US$1,879,335
2.6
Bashan Dror PRESIDENT AND CEO Executive Director
Transaction date
Purchase
Price
1.41
Quantity 16,129 +13.9%
Value US$22,742
2.6
Bashan Dror PRESIDENT AND CEO Executive Director
Transaction date
Purchase
Price
1.40
Quantity 48,387 +71.2%
Value US$67,742
3.7
Schwartz Aharon Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 110,000 +171.9%
Value US$155,815
2.6
Bashan Dror President and CEO Executive Director
Transaction date
Purchase
Price
1.50
Quantity 68,000 +inf%
Value US$102,000
3.7
Schwartz Aharon Non-Executive Director
Transaction date
Purchase
Price
2.43
Quantity 64,000 +inf%
Value US$155,264
Manor Moshe President & CEO Executive Director
Transaction date
Purchase
Price
0.81
Quantity 50,000 +inf%
Value US$40,500
Camber Capital Management LLC Large shareholder
Transaction date
Sale
Price
0.32
Quantity 2,500,000 -18.8%
Value US$792,000
Maimon Yossi Vice President & CFO Officer
Transaction date
Purchase
Price
0.78
Quantity 10,000 +inf%
Value US$7,800
Camber Capital Management LLC Large shareholder
Transaction date
Purchase
Price
1.03
Quantity 423 +0.0%
Value US$436
Camber Capital Management LLC Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 4,000,000 +43.1%
Value US$4,000,000
Bio-Cell Ltd Large shareholder
Transaction date
Sale
Price
2.47
Quantity 4,400,000 -30.4%
Value US$10,868,000
Bronfeld Zeev Non-Executive Director Large shareholder
Transaction date
Sale
Price
2.47
Quantity 4,400,000 -30.4%
Value US$10,868,000
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.07
Quantity 2,330 -0.0%
Value US$11,813
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.08
Quantity 5,000 -0.1%
Value US$25,400
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.07
Quantity 5,000 -0.1%
Value US$25,350
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.05
Quantity 100,000 -2.0%
Value US$505,000
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.70
Quantity 10,000 -0.2%
Value US$57,000
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.71
Quantity 5,000 -0.1%
Value US$28,550
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.72
Quantity 10,000 -0.2%
Value US$57,200
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.75
Quantity 3,000 -0.1%
Value US$17,250
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.79
Quantity 300 -0.0%
Value US$1,737
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.95
Quantity 1,898 -0.0%
Value US$11,293
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.92
Quantity 2,500 -0.0%
Value US$14,800
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.91
Quantity 2,500 -0.0%
Value US$14,775
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.82
Quantity 10,000 -0.2%
Value US$58,200
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.73
Quantity 3,435 -0.1%
Value US$19,683
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.71
Quantity 5,000 -0.1%
Value US$28,550
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.71
Quantity 700 -0.0%
Value US$3,997
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.69
Quantity 2,000 -0.0%
Value US$11,380
Akirov Alfred Non-Executive Director
Transaction date
Sale
Price
5.68
Quantity 2,000 -0.0%
Value US$11,360
Almon Einat Brill SVP, Product Development Officer
Transaction date
Planned sale
Price
7.13
Quantity 166,848 -100.0%
Value US$1,189,626
Aviezer David President & CEO Executive Director
Transaction date
Planned sale
Price
7.13
Quantity 450,000 -100.0%
Value US$3,208,500
Maimon Yossi VP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
7.13
Quantity 125,964 -100.0%
Value US$898,123
Almon Einat Brill VP, Product Development Officer
Transaction date
Planned sale
Price
9.29
Quantity 15,000 -100.0%
Value US$139,350
Almon Einat Brill VP, Product Development Officer
Transaction date
Planned sale
Price
9.08
Quantity 20,000 -100.0%
Value US$181,600
Maimon Yossi VP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
8.16
Quantity 31,500 -100.0%
Value US$257,040
Almon Einat Brill VP, Product Development Officer
Transaction date
Planned sale
Price
8.16
Quantity 22,500 -100.0%
Value US$183,600
Shaaltiel Yoseph Executive VP, R&D Executive Director
Transaction date
Planned sale
Price
7.00
Quantity 4,619 -0.6%
Value US$32,333
Shaaltiel Yoseph Executive VP, R&D Executive Director
Transaction date
Planned sale
Price
7.00
Quantity 50,000 -5.4%
Value US$350,000
Shaaltiel Yoseph Executive VP, R&D Executive Director
Transaction date
Planned sale
Price
7.08
Quantity 202,700 -17.8%
Value US$1,435,116
Bar-Shalev Amos Non-Executive Director
Transaction date
Purchase
Price
8.20
Quantity 680 +68.0%
Value US$5,576
Bar-Shalev Amos Non-Executive Director
Transaction date
Purchase
Price
8.68
Quantity 1,000 +inf%
Value US$8,680
Hurvitz Eli Non-Executive Director
Transaction date
Sale
Price
10.76
Quantity 250,000 -14.2%
Value US$2,690,000
Hurvitz Eli Non-Executive Director
Transaction date
Sale
Price
10.00
Quantity 1,121,967 -38.9%
Value US$11,219,670
Aviezer David CEO and President Executive Director
Transaction date
Planned sale
Price
9.36
Quantity 34,238 -100.0%
Value US$320,468
Aviezer David CEO and President Executive Director
Transaction date
Planned sale
Price
9.45
Quantity 60,000 -100.0%
Value US$567,000
Almon Einat Brill VP, Product Development Officer
Transaction date
Planned sale
Price
9.43
Quantity 38,320 -100.0%
Value US$361,358
Shaaltiel Yoseph Executive VP, R&D Executive Director
Transaction date
Planned sale
Price
9.43
Quantity 43,120 -3.3%
Value US$406,622
Almon Einat Brill VP, Product Development Officer
Transaction date
Planned sale
Price
9.39
Quantity 23,680 -100.0%
Value US$222,355
Maimon Yossi VP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
9.35
Quantity 40,300 -100.0%
Value US$376,805
Shaaltiel Yoseph Executive VP, R&D Executive Director
Transaction date
Planned sale
Price
9.39
Quantity 25,680 -1.9%
Value US$241,135
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.55
Quantity 974 -0.0%
Value US$7,354
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.54
Quantity 2,300 -0.0%
Value US$17,342
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.53
Quantity 1,700 -0.0%
Value US$12,801
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.52
Quantity 1,100 -0.0%
Value US$8,272
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.51
Quantity 750 -0.0%
Value US$5,632
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.50
Quantity 12,300 -0.2%
Value US$92,250
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.48
Quantity 3,716 -0.0%
Value US$27,796
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.47
Quantity 3,200 -0.0%
Value US$23,904
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.45
Quantity 1,800 -0.0%
Value US$13,410
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.44
Quantity 50,900 -0.7%
Value US$378,696
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.43
Quantity 5,596 -0.1%
Value US$41,578
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.42
Quantity 1,400 -0.0%
Value US$10,388
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.41
Quantity 8,284 -0.1%
Value US$61,384
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.40
Quantity 13,200 -0.2%
Value US$97,680
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.39
Quantity 1,600 -0.0%
Value US$11,824
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.38
Quantity 9,254 -0.1%
Value US$68,295
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.37
Quantity 4,179 -0.1%
Value US$30,799
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.35
Quantity 5,821 -0.1%
Value US$42,784
FROST PHILLIP MD ET AL Large shareholder
Transaction date
Sale
Price
7.62
Quantity 1,216 -0.0%
Value US$9,266
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-23 2025-12-19 B Purchase
2.6
Bashan Dror

PRESIDENT AND CEO

Executive Director
56,389 -12.7%
119.29
US$1,992,998 		56,389 -12.7% 119.29 US$1,992,998
2025-11-19 2025-11-18 S Sale
1.3
Bar-Shalev Amos
Non-Executive Director
64,768 -7.5%
185.62
US$3,764,391 		64,768 -7.5% 185.62 US$3,764,391
2025-08-12 2025-06-10 B Purchase
3.7
Schwartz Aharon
Non-Executive Director
75,499 +12.4%
14.10
US$1,879,335 		75,499 +12.4% 14.10 US$1,879,335
2023-10-20 2023-10-19 B Purchase
2.6
Bashan Dror

PRESIDENT AND CEO

Executive Director
16,129 +13.9%
1.41
US$22,742 		16,129 +13.9% 1.41 US$22,742
2023-10-20 2023-10-19 B Purchase
2.6
Bashan Dror

PRESIDENT AND CEO

Executive Director
48,387 +71.2%
1.40
US$67,742 		48,387 +71.2% 1.40 US$67,742
2023-01-05 2023-01-03 B Purchase
3.7
Schwartz Aharon
Non-Executive Director
110,000 +171.9%
1.42
US$155,815 		110,000 +171.9% 1.42 US$155,815
2022-04-13 2022-04-11 B Purchase
2.6
Bashan Dror

President and CEO

Executive Director
68,000 +inf%
1.50
US$102,000 		68,000 +inf% 1.50 US$102,000
2021-06-03 2021-06-03 S Sale
4.0
Dexcel Pharma Technologies Ltd.
Large shareholder
857,506 -19.1%
2.25
US$1,932,304 		857,506 -19.1% 2.25 US$1,932,304
2021-06-03 2021-06-02 S Sale
4.0
Dexcel Pharma Technologies Ltd.
Large shareholder
61,211 -1.3%
2.56
US$156,553 		61,211 -1.3% 2.56 US$156,553
2020-04-13 2020-04-07 B Purchase
3.7
Schwartz Aharon
Non-Executive Director
64,000 +inf%
2.43
US$155,264 		64,000 +inf% 2.43 US$155,264
2017-05-16 2017-05-16 B Purchase Manor Moshe

President & CEO

Executive Director
50,000 +inf%
0.81
US$40,500 		50,000 +inf% 0.81 US$40,500
2016-12-06 2016-12-02 S Sale Camber Capital Management LLC Large shareholder
2,500,000 -18.8%
0.32
US$792,000 		2,500,000 -18.8% 0.32 US$792,000
2015-12-15 2015-12-14 B Purchase Maimon Yossi

Vice President & CFO

Officer
10,000 +inf%
0.78
US$7,800 		10,000 +inf% 0.78 US$7,800
2015-10-20 2015-10-19 B Purchase Camber Capital Management LLC Large shareholder
423 +0.0%
1.03
US$436 		423 +0.0% 1.03 US$436
2015-10-20 2015-10-19 B Purchase Camber Capital Management LLC Large shareholder
4,000,000 +43.1%
1.00
US$4,000,000 		4,000,000 +43.1% 1.00 US$4,000,000
2014-08-15 2014-08-13 S Sale Bio-Cell Ltd Large shareholder
4,400,000 -30.4%
2.47
US$10,868,000 		4,400,000 -30.4% 2.47 US$10,868,000
2014-08-15 2014-08-13 S Sale Bronfeld Zeev Non-Executive Director Large shareholder
4,400,000 -30.4%
2.47
US$10,868,000 		4,400,000 -30.4% 2.47 US$10,868,000
2013-08-16 2013-08-15 S Sale Akirov Alfred Non-Executive Director
2,330 -0.0%
5.07
US$11,813 		2,330 -0.0% 5.07 US$11,813
2013-08-16 2013-08-14 S Sale Akirov Alfred Non-Executive Director
5,000 -0.1%
5.08
US$25,400 		5,000 -0.1% 5.08 US$25,400
2013-08-16 2013-08-14 S Sale Akirov Alfred Non-Executive Director
5,000 -0.1%
5.07
US$25,350 		5,000 -0.1% 5.07 US$25,350
2013-08-16 2013-08-14 S Sale Akirov Alfred Non-Executive Director
100,000 -2.0%
5.05
US$505,000 		100,000 -2.0% 5.05 US$505,000
2013-03-14 2013-03-12 S Sale Akirov Alfred Non-Executive Director
10,000 -0.2%
5.70
US$57,000 		10,000 -0.2% 5.70 US$57,000
2013-03-12 2013-03-11 S Sale Akirov Alfred Non-Executive Director
5,000 -0.1%
5.71
US$28,550 		5,000 -0.1% 5.71 US$28,550
2013-03-12 2013-03-11 S Sale Akirov Alfred Non-Executive Director
10,000 -0.2%
5.72
US$57,200 		10,000 -0.2% 5.72 US$57,200
2013-03-12 2013-03-11 S Sale Akirov Alfred Non-Executive Director
3,000 -0.1%
5.75
US$17,250 		3,000 -0.1% 5.75 US$17,250
2013-03-12 2013-03-11 S Sale Akirov Alfred Non-Executive Director
300 -0.0%
5.79
US$1,737 		300 -0.0% 5.79 US$1,737
2013-03-12 2013-03-08 S Sale Akirov Alfred Non-Executive Director
1,898 -0.0%
5.95
US$11,293 		1,898 -0.0% 5.95 US$11,293
2013-03-12 2013-03-08 S Sale Akirov Alfred Non-Executive Director
2,500 -0.0%
5.92
US$14,800 		2,500 -0.0% 5.92 US$14,800
2013-03-12 2013-03-08 S Sale Akirov Alfred Non-Executive Director
2,500 -0.0%
5.91
US$14,775 		2,500 -0.0% 5.91 US$14,775
2013-03-12 2013-03-08 S Sale Akirov Alfred Non-Executive Director
10,000 -0.2%
5.82
US$58,200 		10,000 -0.2% 5.82 US$58,200
2013-03-08 2013-03-07 S Sale Akirov Alfred Non-Executive Director
3,435 -0.1%
5.73
US$19,683 		3,435 -0.1% 5.73 US$19,683
2013-03-08 2013-03-07 S Sale Akirov Alfred Non-Executive Director
5,000 -0.1%
5.71
US$28,550 		5,000 -0.1% 5.71 US$28,550
2013-03-08 2013-03-06 S Sale Akirov Alfred Non-Executive Director
700 -0.0%
5.71
US$3,997 		700 -0.0% 5.71 US$3,997
2013-03-08 2013-03-06 S Sale Akirov Alfred Non-Executive Director
2,000 -0.0%
5.69
US$11,380 		2,000 -0.0% 5.69 US$11,380
2013-03-08 2013-03-06 S Sale Akirov Alfred Non-Executive Director
2,000 -0.0%
5.68
US$11,360 		2,000 -0.0% 5.68 US$11,360
2012-05-04 2012-05-02 PlS Planned sale Almon Einat Brill

SVP, Product Development

Officer
166,848 -100.0%
7.13
US$1,189,626 		166,848 -100.0% 7.13 US$1,189,626
2012-05-04 2012-05-02 PlS Planned sale Aviezer David

President & CEO

Executive Director
450,000 -100.0%
7.13
US$3,208,500 		450,000 -100.0% 7.13 US$3,208,500
2012-05-04 2012-05-02 PlS Planned sale Maimon Yossi

VP, Chief Financial Officer

Officer
125,964 -100.0%
7.13
US$898,123 		125,964 -100.0% 7.13 US$898,123
2010-10-06 2010-10-06 PlS Planned sale Almon Einat Brill

VP, Product Development

Officer
15,000 -100.0%
9.29
US$139,350 		15,000 -100.0% 9.29 US$139,350
2010-10-06 2010-10-05 PlS Planned sale Almon Einat Brill

VP, Product Development

Officer
20,000 -100.0%
9.08
US$181,600 		20,000 -100.0% 9.08 US$181,600
2010-09-08 2010-09-07 PlS Planned sale Maimon Yossi

VP, Chief Financial Officer

Officer
31,500 -100.0%
8.16
US$257,040 		31,500 -100.0% 8.16 US$257,040
2010-09-08 2010-09-07 PlS Planned sale Almon Einat Brill

VP, Product Development

Officer
22,500 -100.0%
8.16
US$183,600 		22,500 -100.0% 8.16 US$183,600
2010-08-09 2010-08-06 PlS Planned sale Shaaltiel Yoseph

Executive VP, R&D

Executive Director
4,619 -0.6%
7.00
US$32,333 		4,619 -0.6% 7.00 US$32,333
2010-03-25 2010-03-25 PlS Planned sale Shaaltiel Yoseph

Executive VP, R&D

Executive Director
50,000 -5.4%
7.00
US$350,000 		50,000 -5.4% 7.00 US$350,000
2010-03-25 2010-03-24 PlS Planned sale Shaaltiel Yoseph

Executive VP, R&D

Executive Director
202,700 -17.8%
7.08
US$1,435,116 		202,700 -17.8% 7.08 US$1,435,116
2009-12-09 2009-12-02 B Purchase Bar-Shalev Amos Non-Executive Director
680 +68.0%
8.20
US$5,576 		680 +68.0% 8.20 US$5,576
2009-12-09 2009-12-02 B Purchase Bar-Shalev Amos Non-Executive Director
1,000 +inf%
8.68
US$8,680 		1,000 +inf% 8.68 US$8,680
2009-11-13 2009-11-12 S Sale Hurvitz Eli Non-Executive Director
250,000 -14.2%
10.76
US$2,690,000 		250,000 -14.2% 10.76 US$2,690,000
2009-11-13 2009-11-12 S Sale Hurvitz Eli Non-Executive Director
1,121,967 -38.9%
10.00
US$11,219,670 		1,121,967 -38.9% 10.00 US$11,219,670
2009-10-21 2009-10-21 PlS Planned sale Aviezer David

CEO and President

Executive Director
34,238 -100.0%
9.36
US$320,468 		34,238 -100.0% 9.36 US$320,468
2009-10-21 2009-10-20 PlS Planned sale Aviezer David

CEO and President

Executive Director
60,000 -100.0%
9.45
US$567,000 		60,000 -100.0% 9.45 US$567,000
2009-10-19 2009-10-19 PlS Planned sale Almon Einat Brill

VP, Product Development

Officer
38,320 -100.0%
9.43
US$361,358 		38,320 -100.0% 9.43 US$361,358
2009-10-19 2009-10-19 PlS Planned sale Shaaltiel Yoseph

Executive VP, R&D

Executive Director
43,120 -3.3%
9.43
US$406,622 		43,120 -3.3% 9.43 US$406,622
2009-10-19 2009-10-16 PlS Planned sale Almon Einat Brill

VP, Product Development

Officer
23,680 -100.0%
9.39
US$222,355 		23,680 -100.0% 9.39 US$222,355
2009-10-19 2009-10-16 PlS Planned sale Maimon Yossi

VP, Chief Financial Officer

Officer
40,300 -100.0%
9.35
US$376,805 		40,300 -100.0% 9.35 US$376,805
2009-10-19 2009-10-16 PlS Planned sale Shaaltiel Yoseph

Executive VP, R&D

Executive Director
25,680 -1.9%
9.39
US$241,135 		25,680 -1.9% 9.39 US$241,135
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
974 -0.0%
7.55
US$7,354 		974 -0.0% 7.55 US$7,354
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
2,300 -0.0%
7.54
US$17,342 		2,300 -0.0% 7.54 US$17,342
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
1,700 -0.0%
7.53
US$12,801 		1,700 -0.0% 7.53 US$12,801
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
1,100 -0.0%
7.52
US$8,272 		1,100 -0.0% 7.52 US$8,272
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
750 -0.0%
7.51
US$5,632 		750 -0.0% 7.51 US$5,632
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
12,300 -0.2%
7.50
US$92,250 		12,300 -0.2% 7.50 US$92,250
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
3,716 -0.0%
7.48
US$27,796 		3,716 -0.0% 7.48 US$27,796
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
3,200 -0.0%
7.47
US$23,904 		3,200 -0.0% 7.47 US$23,904
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
1,800 -0.0%
7.45
US$13,410 		1,800 -0.0% 7.45 US$13,410
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
50,900 -0.7%
7.44
US$378,696 		50,900 -0.7% 7.44 US$378,696
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
5,596 -0.1%
7.43
US$41,578 		5,596 -0.1% 7.43 US$41,578
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
1,400 -0.0%
7.42
US$10,388 		1,400 -0.0% 7.42 US$10,388
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
8,284 -0.1%
7.41
US$61,384 		8,284 -0.1% 7.41 US$61,384
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
13,200 -0.2%
7.40
US$97,680 		13,200 -0.2% 7.40 US$97,680
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
1,600 -0.0%
7.39
US$11,824 		1,600 -0.0% 7.39 US$11,824
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
9,254 -0.1%
7.38
US$68,295 		9,254 -0.1% 7.38 US$68,295
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
4,179 -0.1%
7.37
US$30,799 		4,179 -0.1% 7.37 US$30,799
2009-09-11 2009-09-10 S Sale FROST PHILLIP MD ET AL Large shareholder
5,821 -0.1%
7.35
US$42,784 		5,821 -0.1% 7.35 US$42,784
2009-09-11 2009-09-09 S Sale FROST PHILLIP MD ET AL Large shareholder
1,216 -0.0%
7.62
US$9,266 		1,216 -0.0% 7.62 US$9,266
Explore more

More insider trading research around Protalix Biotherapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America